Leuven, Belgium, 22 January 2015 - Pursuant to Belgian transparency legislation (Law of 2 May 2007), ThromboGenics NV (Euronext Brussels: THR) received a transparency notification on 16 January 2015 from Norges Bank.

Norges Bank notified that on 16 January 2015, it held 1,093,136 shares, representing 3.03% of the current 36,094,349 outstanding ThromboGenics shares.  Norges Bank is the central bank of Norway. All investments are executed by Norges Bank acting as principal and all holdings are registered in the name of Norges Bank.

distributed by